US veterans who were exposed to Agent Orange have an increased risk of myeloproliferative neoplasms. The novel JAK1-sparing inhibitor pacritinib is effective at reducing spleen enlargement and disease burden in MF patients. The safety and efficacy of luspatercept is favorable for treating anemia in patients with myelofibrosis. Patients admitted for atrial fibrillation who have myeloproliferative neoplasms have an increased risk of bleeding. Extending colorectal cancer screening to older populations using stool testing results in more life years gained. People with a history of skin cancer lack sufficient knowledge on photoprotection, study finds.